Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma

por Sato, Shunsuke, Genda, Takuya, Hirano, Katsuharu, Tsuzura, Hironori, Narita, Yutaka, Kanemitsu, Yoshio, Kikuchi, Tetsu, Iijima, Katsuyori, Wada, Ryo, Ichida, Takafumi
Publicado 2012

On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)...

por Murata, Ayato, Amano, Nozomi, Sato, Sho, Tsuzura, Hironori, Tomishima, Ko, Sato, Shunsuke, Matsumoto, Kohei, Shimada, Yuji, Iijima, Katsuyori, Genda, Takuya
Publicado 2020

Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist

por Hayashida, Sho, Sato, Shunsuke, Shimada, Yuji, Tsuzura, Hironori, Ikeda, Yuji, Takahashi, Sho, Sato, Sho, Amano, Nozomi, Murata, Ayato, Nagahara, Akihito, Genda, Takuya
Publicado 2020

Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradi...

por Sato, Shunsuke, Tsuzura, Hironori, Kita, Yuji, Ikeda, Yuji, Kabemura, Daishi, Sato, Sho, Amano, Nozomi, Yatagai, Noboru, Murata, Ayato, Shimada, Yuji, Genda, Takuya
Publicado 2021

Hepatitis B Surface Antigen Decline during Sofosbuvir and Ribavirin Therapy in Hepatitis B Inactive Carriers Who Were Co-infected with Hepatitis C

por Sato, Shunsuke, Tsuzura, Hironori, Kita, Yuji, Ikeda, Yuji, Kabemura, Daishi, Sato, Sho, Amano, Nozomi, Yatagai, Noboru, Murata, Ayato, Shimada, Yuji, Genda, Takuya
Publicado 2021

Successful Management of Hemosuccus Pancreaticus due to Pancreatic Adenocarcinoma by Chemoradiotherapy

por Tomishima, Ko, Fujisawa, Toshio, Sato, Sho, Amano, Nozomi, Murata, Ayato, Tsuzura, Hironori, Sato, Shunsuke, Matsumoto, Kouhei, Shimada, Yuji, Wada, Ryo, Genda, Takuya, Isayama, Hiroyuki
Publicado 2020

Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis

por Tsuzura, Hironori, Genda, Takuya, Sato, Shunsuke, Murata, Ayato, Kanemitsu, Yoshio, Narita, Yutaka, Ishikawa, Sachiko, Kikuchi, Tetsu, Mori, Masashi, Hirano, Katsuharu, Iijima, Katsuyori, Wada, Ryo, Ichida, Takafumi
Publicado 2014

Mucinous Cystadenocarcinoma of the Pancreas with Cyst Infection in a Male Patient

por Tomishima, Ko, Fujisawa, Toshio, Fukumura, Yuki, Ushio, Mako, Sato, Sho, Amano, Nozomi, Murata, Ayato, Tsuzura, Hironori, Sato, Shunsuke, Matsumoto, Kouhei, Shimada, Yuji, Genda, Takuya, Isayama, Hiroyuki
Publicado 2020

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication

por Murata, Ayato, Genda, Takuya, Ichida, Takafumi, Amano, Nozomi, Sato, Sho, Tsuzura, Hironori, Sato, Shunsuke, Narita, Yutaka, Kanemitsu, Yoshio, Shimada, Yuji, Hirano, Katsuharu, Iijima, Katsuyori, Wada, Ryo, Nagahara, Akihito, Watanabe, Sumio
Publicado 2016

Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein

por Sato, Shunsuke, Genda, Takuya, Ichida, Takafumi, Amano, Nozomi, Sato, Sho, Murata, Ayato, Tsuzura, Hironori, Narita, Yutaka, Kanemitsu, Yoshio, Hirano, Katsuharu, Shimada, Yuji, Iijima, Katsuyori, Wada, Ryo, Nagahara, Akihito, Watanabe, Sumio
Publicado 2016

Does restricting fluid volume impact post-ERCP pancreatitis in patient with heart disease?

por Tomishima, Ko, Ishii, Shigeto, Fujisawa, Toshio, Yatagai, Noboru, Kabemura, Daishi, Sato, Sho, Amano, Nozomi, Murata, Ayato, Tsuzura, Hironori, Sato, Shunsuke, Matsumoto, Kouhei, Shimada, Yuji, Genda, Takuya, Nagahara, Akihito, Isayama, Hiroyuki
Publicado 2021